Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475978![]() (US10865208, Compound I-36 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476097![]() (US10865208, Compound I-152 | [(2R,3R,4S,5R)-5-{4-a...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475984![]() (US10865208, Compound I-42 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475988![]() (US10865208, Compound I-46 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475992![]() (US10865208, Compound I-50 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475999![]() (US10865208, Compound I-56 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476001![]() (US10865208, Compound I-58 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476005![]() (US10865208, Compound I-62 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476008![]() (US10865208, Compound I-65 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476012![]() (US10865208, Compound I-69 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476022![]() (US10865208, Compound I-79 | [(2R,3S,4R,5R)-5-(4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476032![]() (US10865208, Compound I-89 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476046![]() (US10865208, Compound I-103 | {(2R,3R,4S,5R)-5-[4-a...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476056![]() (US10865208, Compound I-113 | {(2R,3R,4S,5R)-5-[4-a...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476057![]() (US10865208, Compound I-114 | [(2R,3R,4S,5R)-5-{4-a...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476061![]() (US10865208, Compound I-118 | {(2R,3R,4S,5R)-5-[4-a...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476092![]() (US10865208, Compound I-147 | {(2R,3R,4S,5R)-5-[4-a...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476093![]() (US10865208, Compound I-148 | [(2R,3R,4S,5R)-5-{4-a...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475982![]() (US10865208, Compound I-40 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <20 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475954![]() (US10865208, Compound I-13 | [(2R,3S,4R,5R)-5-(4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475969![]() (US10865208, Compound I-27 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475973![]() (US10865208, Compound I-31 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475974![]() (US10865208, Compound I-32 | [(2R,3S,4R,5R)-5-(4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475975![]() (US10865208, Compound I-33 | [(2R,3S,4R,5R)-5-(4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475977![]() (US10865208, Compound I-35 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475980![]() (US10865208, Compound I-38 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475981![]() (US10865208, Compound I-39 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475983![]() (US10865208, Compound I-41 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475985![]() (US10865208, Compound I-43 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475986![]() (US10865208, Compound I-44 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475987![]() (US10865208, Compound I-45 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475993![]() (US10865208, Compound I-51 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475994![]() (US10865208, Compound I-52 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475995![]() (US10865208, Compound I-53 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM475996![]() (US10865208, Compound I-54 | [(2R,3S,4R,5R)-5-(4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476002![]() (US10865208, Compound I-59 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476004![]() (US10865208, Compound I-61 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476006![]() (US10865208, Compound I-63 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476007![]() (US10865208, Compound I-64 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476009![]() (US10865208, Compound I-66 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476016![]() (US10865208, Compound I-73 | [(2R,3S,4R,5R)-5-(4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476020![]() (US10865208, Compound I-77 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476021![]() (US10865208, Compound I-78 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476025![]() (US10865208, Compound I-82 | {(2R,3S,4R,5R)-5-[4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476026![]() (US10865208, Compound I-83 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476028![]() (US10865208, Compound I-85 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476031![]() (US10865208, Compound I-88 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476033![]() (US10865208, Compound I-90 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476034![]() (US10865208, Compound I-91 | [(2R,3S,4R,5R)-5-{4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ubiquitin-like modifier-activating enzyme ATG7 (Homo sapiens (Human)) | BDBM476040![]() (US10865208, Compound I-97 | [(2R,3R,4S,5R)-5-(4-am...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
MILLENNIUM PHARMACEUTICALS, INC. US Patent | Assay Description The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ... | US Patent US10865208 (2020) BindingDB Entry DOI: 10.7270/Q23B6366 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 231 total ) | Next | Last >> |